- Seong Hun Kim, Seung Ok Lee. Developing Consilience Medicine: Positron Emission Tomography Scan and Transcriptomics in Pancreatic Cancer. Gut and Liver 2019;13:225

- Su-Hyeong Park, In-Cheon Kang, Seung-Soo Hong, Ha-Yan Kim, Ho-Kyoung Hwang, Chang-Moo Kang. Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma—Cohort Study. Cancers 2024;16:1844

- Jing Gao, Xinyun Huang, Hongping Meng, Miao Zhang, Xiaozhe Zhang, Xiaozhu Lin, Biao Li. Performance of Multiparametric Functional Imaging and Texture Analysis in Predicting Synchronous Metastatic Disease in Pancreatic Ductal Adenocarcinoma Patients by Hybrid PET/MR: Initial Experience. Front. Oncol. 2020;10

- Farshad Moradi, Andrei Iagaru. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer. Seminars in Nuclear Medicine 2020;50:434

- Sung Hwan Lee, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang. MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer. Cell Oncol. 2021;44:1363

- Ningzhen Fu, Kai Qin, Jingfeng Li, Jiabin Jin, Yu Jiang, Xiaxing Deng, Baiyong Shen. Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate‐adjusted analysis at the pre‐adjuvant chemotherapy timing. Cancer Medicine 2022;11:3397

- Keinosuke Ishido, Kenichi Hakamada, Norihisa Kimura, Takuya Miura, Taiichi Wakiya. Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma. Annals of Gastroent Surgery 2021;5:7
